Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

This Pharma Stock Is Poised to Keep Outperforming the S&P 500

AstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company should be able to repeat this feat over…

ANALYSE-FLASH: Goldman startet Astrazeneca mit Buy - Ziel 15200 Pence

NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien von Astrazeneca bei einem Kursziel…

Goldman startet Astrazeneca mit Buy - Ziel 15200 Pence

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien von Astrazeneca bei einem Kursziel von…

5 Biggest Pharmaceutical ETFs in 2024

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the…

AstraZeneca Just Massively One-Upped Pfizer. Heres What It Means for the Stock

Both businesses have road maps for the future, but one is better.…

AstraZeneca Just Massively One-Upped Pfizer. Heres What It Means for the Stock

…

AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal

AstraZenecas (AZN) shares decline as it fails to achieve statistically significant overall survival data in a late-stage NSCLC study on…

AstraZeneca: Neues Kursziel

New York (www.aktiencheck.de) - Rating-Update: Mark Purcell, Analyst von Morgan Stanley, stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN:weiterhin mit…

Dato-DXd improved OS in nonsquamous lung cancer

This announcement contains inside information 27 May 2024 Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small…

Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89%

The Global Topical Wound Agents Market Size was valued at USD 1.9 Billion in 2023 and the Global Topical Wound…

„Chemotherapie ersetzen“ – AstraZeneca plant den nächsten Blockbuster

Durch sein Corona-Vakzin wurde AstraZeneca einer breiten Öffentlichkeit bekannt. Der Impfstoff ist inzwischen Geschichte. Nun präsentierte Konzernchef Soriot jüngst neue…

AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, Im Pausing For Breath

…

Pharma Stock Roundup: AZNs 2030 Sales Target, PFEs New Cost Cut Plan & More

AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase…

‘Gothenburg is extremely important for us’

Sweden is a vital part of AstraZeneca. And the company plays a key role in Sweden and Gothenburg’s business environment.…

Nona Biosciences and AstraZeneca sign global license and option agreement

…

AstraZeneca formuliert neue ambitionierte Ziele - Analysten gespalten - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

JPMORGAN stuft ASTRAZENECA auf Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 13000 Pence auf…

Stocks making the biggest moves midday: Peloton, Lam Research, Lowes, AstraZeneca and more

These are the stocks posting the largest moves midday.…

AstraZeneca strebt für 2030 einen Gesamtumsatz von 80 Milliarden US-Dollar und ein nachhaltiges Wachstum nach 2030 an

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca gab heute sein ehrgeiziges Ziel bekannt, 2030 einen Gesamtumsatz von USD 80 Mrd. zu erzielen – gegenüber…

FTSE 100 dips on rates concerns, AstraZeneca outlines ambitious plans

The FTSE 100 dipped on Tuesday after investors were served an unwelcome reminder that the Federal Reserve rate cuts were…

AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters

AstraZeneca aims for $80 billion in total revenue by 2030…

AstraZeneca shares rise as pharma group unveils 2030 revenue target By Investing.com

AstraZeneca shares rise as pharma group unveils 2030 revenue target…

AstraZeneca: Der Pharma-Konzern setzt sich ehrgeizige Wachstumsziele - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

AstraZeneca targets $80 billion in total revenue by 2030 in post-Covid era

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including…

Antiandrogens Market Insights and Projections to 2030: An $8.7 Billion Landscape Dominated by Pfizer, Astellas Pharma, Roche, AstraZeneca, and Abbott Labs

Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Antiandrogens Market Report: Trends, Forecast and Competitive Analysis to 2030"…

Astra Aims to Almost Double Sales to $80 Billion by 2030

Astrazeneca CFO Aradhana Sarin discusses the companys growth plans with Guy Johnson, Kriti Gupta and Anna Edwards on Markets Today.…

AstraZeneca aims to boost revenues to $80bn by 2030

AstraZeneca PLC (LSE:AZN) aims to grow its revenue by about 75% to $80 billion by 2030, driven by the launch…

European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target By Investing.com

European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target…

FTSE 100 live: Blue-chips fall, IMF warns against UK tax cuts, US stocks to open lower

FTSE 100 falls 29 points to 8395 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 live: Blue-chips fall out of bed, Pennon hits water companies, AstraZeneca rises

FTSE 100 falls 22 points to 8402 Pennon leads water companies lower AstraZeneca sets new targets for decade 8.28am: Water…

FTSE 100 live: Blue-chips almost flat as IMF warns against UK tax cuts

FTSE 100 falls 7 points to 8417 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 live: Blue-chips set to slide on oil price drop, AstraZeneca sets new targets

7.39am: Kingfisher sales down but guidance maintained B&Q and Screwfix owner Kingfisher PLC (LSE:KGF) reported a 0.9% decline in like-for-like (LFL) sales...…

FTSE 100 live: Blue-chips fall as Pennon hits water firms, AstraZeneca and Greencore climb

FTSE 100 falls 37 points to 8387 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets for…

FTSE 100 live: Blue-chips fall as Pennon hits water firms, AstraZeneca up Greencore soars

FTSE 100 falls 37 points to 8387 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets for…

FTSE 100 closes lower as IMF warns against UK tax cuts

FTSE 100 falls 7 points to 8416 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 live: Blue-chips fall out of bed, AstraZeneca a rare riser

8.07am: FTSE 100 falls out of bed The FTSE 100 has dropped 30 points to 8394 in initial trades, with all…

FTSE 100 live: Blue-chips fall as Pennon hits water companies, AstraZeneca and Greencore climb

FTSE 100 falls 34 points to 8390 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

AstraZeneca to deliver $80bn revenue by 2030

21 May 2024 AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030 Launch of 20…

Ihre wichtigsten Termine: Heute im Fokus: AstraZeneca, Kingfisher, Shell, Macys & Assicurazioni Generali

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.…

AstraZeneca, Amgen release mid-stage data on Tezspire for COPD

…

[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

dpa-AFX ProFeed